Frameless linac-based radiosurgery for benign intracranial tumors treated with HyperArc: analysis of tumor control and toxicity - Takeaways - MDSpire

Frameless linac-based radiosurgery for benign intracranial tumors treated with HyperArc: analysis of tumor control and toxicity

  • By

  • Whitney S. Hotsinpiller

  • Evan M. Thomas

  • Ian Tsekouras

  • Richard A. Popple

  • Markus Bredel

  • Christopher D. Willey

  • Barton L. Guthrie

  • James M. Markert

  • Kristen O. Riley

  • John B. Fiveash

  • Drexell Hunter Boggs

  • October 21, 2025

  • 0 min

Share

  • 1

    HyperArc™ is an automated VMAT system for linac-based radiosurgery, enhancing efficiency and quality in treating benign intracranial tumors.

  • 2

    The study investigates tumor control and toxicity outcomes for patients treated with HyperArc™ between May 2018 and October 2021.

  • 3

    Patients were simulated using an Encompass™ mask, with CT and MR imaging for accurate target delineation and treatment planning.

  • 4

    Plans were created using flattening filter-free beams, ensuring high dose rates and minimal toxicity to surrounding healthy tissue.

  • 5

    Quality assurance processes demonstrated high geometric accuracy and adherence to recommended SRS tolerance values throughout the study.

Original Source(s)

Related Content